Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploiting ALDH1A2 and ALDH1A3 isoform variability for crystallisation screening. | Biochem Biophys Res Commun | 2025 | 40829477 | PubTator, text mining | PubMed |
| Genotypic and phenotypic spectrum of anophthalmia/microphthalmia in families from Khyber Pakhtunkhwa, Pakistan. | J Hum Genet | 2025 | 40820231 | PubTator, text mining | PubMed |
| ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. | Oncogene | 2025 | 40781158 | PubTator, text mining | PubMed |
| Cancer stem cells: landscape, challenges and emerging therapeutic innovations. | Signal Transduct Target Ther | 2025 | 40759634 | PubTator, text mining | PubMed |
| DHRS13 suppresses differentiation and mitophagy in glioma via retinoic acid and mitochondrial reactive oxygen species. | Nat Commun | 2025 | 40739132 | PubTator, text mining | PubMed |
| In vivo CRISPR screening identifies POU3F3 as a novel regulator of ferroptosis resistance in hepatocellular carcinoma via retinoic acid signaling. | Cell Commun Signal | 2025 | 40634958 | PubTator, text mining | PubMed |
| Expression of ALDH1 isotypes and its potential as a prognostic and diagnostic marker in patients with muscle invasive bladder cancer. | Sci Rep | 2025 | 40595790 | PubTator, text mining | PubMed |
| Fluorescent substrates enable specific detection and structure-function insights into human aldehyde dehydrogenase isoforms. | Chem Biol Interact | 2025 | 40541648 | PubTator, text mining | PubMed |
| Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug Resistance. | Int J Mol Sci | 2025 | 40507922 | PubTator, text mining | PubMed |
| tsRNA-08614 inhibits glycolysis and histone lactylation by ALDH1A3 to confer oxaliplatin sensitivity in colorectal cancer. | Transl Oncol | 2025 | 40480147 | PubTator, text mining | PubMed |
| The interaction of HT-2 toxin and Akt1 on gene expression regulation in Kashin-Beck disease pathogenesis. | Toxicon | 2025 | 40449756 | PubTator, text mining | PubMed |
| MSstatsTMT Improves Accuracy of Thermal Proteome Profiling. | Mol Cell Proteomics | 2025 | 40441441 | PubTator, text mining | PubMed |
| Opposing effects between retinoic acid and Fibroblast growth factor in patterning the common crus and semicircular canals of the inner ear. | Dev Biol | 2025 | 40436241 | PubTator, text mining | PubMed |
| SYT7 accelerates nasopharyngeal carcinoma progression via ALDH1A3-mediated STAT3 signaling activation. | Oncogenesis | 2025 | 40346036 | PubTator, text mining | PubMed |
| ALDH1A3 Regulates Cellular Senescence and Senescence-Associated Secretome in Prostate Cancer. | Cancers (Basel) | 2025 | 40227735 | PubTator, text mining | PubMed |
| PPAR γ changing ALDH1A3 content to regulate lipid metabolism and inhibit lung cancer cell growth. | Mol Genet Genomics | 2025 | 40198404 | PubTator, text mining | PubMed |
| The potential of ARL4C and its-mediated genes in atherosclerosis and agent development. | Front Pharmacol | 2025 | 40176913 | PubTator, text mining | PubMed |
| Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism. | J Exp Clin Cancer Res | 2025 | 40122809 | PubTator, text mining | PubMed |
| Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes. | Diabetologia | 2025 | 40072535 | PubTator, text mining | PubMed |
| Pancreatic expression of CPT1A is essential for whole body glucose homeostasis by supporting glucose-stimulated insulin secretion. | J Biol Chem | 2025 | 39814231 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=4